Christian Lizak

Director Partnering & Alliances - Collaboration Lead at Molecular Partners

Christian Lizak, PhD has a diverse work experience in the field of biotechnology and biochemistry. Christian is currently serving as the Director Partnering & Alliances - Collaboration Lead at Molecular Partners since 2022. Prior to this, they held the position of Senior Scientist - Manager Business Development at Philogen S.p.A. from 2018 to 2022. Christian also worked as the Group Leader Biochemistry at LimmaTech Biologics AG from 2016 to 2018. Additionally, they have experience as a Postdoctoral Research Fellow at The University of British Columbia from 2014 to 2016. Dr. Lizak started their career as a Postdoctoral Research Associate at ETH Zurich, where they performed structure-function studies and supervised students. Christian also worked as a Master Thesis intern at Roche Diagnostics and as an intern at MorphoSys AG.

Christian Lizak, PhD has a strong education background in the field of Biochemistry and Structural Biology. Christian obtained their Bachelor of Science (B.Sc.) degree from the Technical University of Munich in 2003. Christian then pursued their Master of Science (M.Sc.) degree at the same university, completing it in 2006. During their master's program, they also participated in a research internship at The University of Auckland in 2003-2004.

Following their master's degree, Christian enrolled at ETH Zürich in 2006 and spent five years there, earning their Doctor of Science (Dr. Sc. ETH) degree in Biochemistry and Structural Biology in 2011. Additionally, they attended a training course on X-Ray Methods in Structural Biology at the Cold Spring Harbor Laboratory, although the dates are not provided.

Overall, Christian Lizak, PhD has a comprehensive educational background in biochemistry, with degrees at the bachelor's, master's, and doctoral levels.

Links

Previous companies

ETH Zürich logo
MorphoSys logo
Philogen logo

Org chart

Peers

Timeline

  • Director Partnering & Alliances - Collaboration Lead

    February, 2022 - present

View in org chart